{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:14:50Z","timestamp":1767676490526},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T00:00:00Z","timestamp":1236988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s10067-009-1130-2","type":"journal-article","created":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T09:51:33Z","timestamp":1236937893000},"page":"673-678","source":"Crossref","is-referenced-by-count":16,"title":["Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus"],"prefix":"10.1007","volume":"28","author":[{"given":"Adel A.","family":"Shabana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atef E.","family":"El-Ghawet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen A.","family":"Machaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekbal M.","family":"Abu Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma A.","family":"El-Kady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham","family":"Shaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,14]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2004.07.002","volume":"34","author":"Y Sherer","year":"2004","unstructured":"Sherer Y, Gorstein A, Frizler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34:501\u2013537","journal-title":"Semin Arthritis Rheum"},{"key":"1130_CR2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00002281-200009000-00002","volume":"12","author":"DS Pisetsky","year":"2000","unstructured":"Pisetsky DS (2000) Anti-DNA and autoantibodies. Curr Opin Rheumatol 12:364\u2013368","journal-title":"Curr Opin Rheumatol"},{"key":"1130_CR3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/keh024","volume":"43","author":"JA Simon","year":"2004","unstructured":"Simon JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sanchez-Guerrero J (2004) Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 43:220\u2013224","journal-title":"Rheumatology"},{"key":"1130_CR4","first-page":"377","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF (1982) The 1982 revised criteria for classification of SLE. Arthritis Rheum 25:377\u2013382","journal-title":"Arthritis Rheum"},{"key":"1130_CR5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association (1987): revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumatism 31:315\u2013324","journal-title":"Arthritis Rheumatism"},{"key":"1130_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"AT Masi","year":"1980","unstructured":"Masi AT, Rodnan GP, Medsger TA et al (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"key":"1130_CR7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DA, Urowitz MB, Caron D, Chang DH (1992) And the committee on prognosis studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"key":"1130_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241\u2013250","journal-title":"J Am Soc Nephrol"},{"key":"1130_CR9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1172\/JCI117305","volume":"94","author":"RW Burlingame","year":"1994","unstructured":"Burlingame RW, Boey ML, Starkebaum G (1994) The central role of chromatin in the autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94:784\u2013192","journal-title":"J Clin Invest"},{"key":"1130_CR10","unstructured":"Gockel S, Binder WL (1985) Immunoglobulin class specific of antihistone. Arthritis Rheum (supple) 28:558"},{"key":"1130_CR11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/ard.62.5.431","volume":"62","author":"R Cervera","year":"2003","unstructured":"Cervera R, Vinas O, Ramos-Casals M et al (2003) Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 62:431\u2013434","journal-title":"Ann Rheum Dis"},{"key":"1130_CR12","unstructured":"Gladman DD, Urowitz MB (1997) Systemic lupus erythematosus clinical and laboratory features. In: Klippel JH, Weyond CM, Wortmann RL (eds) Primer on Rheumatic Diseases, 11th edition 250-257"},{"key":"1130_CR13","unstructured":"Kim WU, Kim SI, Yoo WH, Par JH, Min JK, Kim SC, Hong YS, Lee SH, Cho CS, Kim HY (1999) ARDS in SLE patients: Rheumatic Dis. In: Kang-Nam St Mary\u2019s Hospital p. 552-7"},{"key":"1130_CR14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.62.3.272","volume":"62","author":"AP Cairns","year":"2003","unstructured":"Cairns AP, McMillan SA, Crockard AD et al (2003) Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis 62:272\u2013273","journal-title":"Ann Rheum Dis"},{"key":"1130_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4065\/74.3.275","volume":"74","author":"KG Moder","year":"1999","unstructured":"Moder KG, Miller TD, Tazelaer HD (1999) Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 74:275","journal-title":"Mayo Clin Proc"},{"key":"1130_CR16","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1056\/NEJM199611073351903","volume":"335","author":"CA Roldan","year":"1996","unstructured":"Roldan CA, Shively BK, Crawford MH (1996) An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 335:1424\u20131430","journal-title":"N Engl J Med"},{"key":"1130_CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9343(97)80020-4","volume":"103","author":"F Medina","year":"1997","unstructured":"Medina F, Ayala A, Jara LJ, Becerra M, Miranda JM, Fraga A (1997) Acute abdomen is systemic lupus eythematosus: the importance of early laparotomy. Am J Med 103:100\u2013105","journal-title":"Am J Med"},{"key":"1130_CR18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","volume":"129","author":"A Czaja","year":"2001","unstructured":"Czaja A, Homburger H (2001) Antibodies in liver disease. Gastroenterology 129:239","journal-title":"Gastroenterology"},{"key":"1130_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.51.1.61","volume":"51","author":"MG Cohen","year":"1992","unstructured":"Cohen MG, Pollard M, Webb J (1992) Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features. Ann Rheum Dis 51:61\u201366","journal-title":"Ann Rheum Dis"},{"key":"1130_CR20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/ard.61.5.409","volume":"61","author":"KE Moss","year":"2002","unstructured":"Moss KE, Loannou Y, Sutton SM, Hag I, Isenberg DA (2002) Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 61:409\u2013413","journal-title":"Ann Rheum Dis"},{"key":"1130_CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10067-004-1005-5","volume":"24","author":"S Haddouk","year":"2005","unstructured":"Haddouk S, Ben M, Baklouti S, Hachicha J, Bahloul Z, Masmoudi H (2005) Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients. Clin Rheumatol 24:219\u2013222","journal-title":"Clin Rheumatol"},{"issue":"10","key":"1130_CR22","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/art.1780381015","volume":"38","author":"H Chabre","year":"1995","unstructured":"Chabre H, Amoura Z, Piette JC, Godeau P, Bach JF, Koutouzov S (1995) Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 38(10):1485\u20131491","journal-title":"Arthritis Rheum"},{"key":"1130_CR23","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1365-2133.2004.06256.x","volume":"151","author":"S Sato","year":"2004","unstructured":"Sato S, Kodera M, Hasegawa M, Fujimoto M, Takehara K (2004) Antinucleosome antibody is a major autoantibody in localized scleroderma. Br J Dermatol 151:1182\u20131188","journal-title":"Br J Dermatol"},{"key":"1130_CR24","first-page":"109","volume":"57","author":"P Quattrocchi","year":"2005","unstructured":"Quattrocchi P, Barrile A, Bonanno D et al (2005) The role of antinucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases. Reumatismo 57:109\u2013113","journal-title":"Reumatismo"},{"key":"1130_CR25","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/40.12.1405","volume":"40","author":"CT Ravirajan","year":"2001","unstructured":"Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA (2001) An analysis of clinical disease activity and nephritis associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology 40:1405\u20131412","journal-title":"Rheumatology"},{"key":"1130_CR26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1568-9972(02)00083-6","volume":"1","author":"RW Burlingame","year":"2002","unstructured":"Burlingame RW, Cervera R (2002) Anti-chromatin (anti-nucleosome) autoantibodies. Autoimmu Rev 1:321\u2013328","journal-title":"Autoimmu Rev"},{"key":"1130_CR27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1191\/0961203302lu247oa","volume":"11","author":"G Schett","year":"2002","unstructured":"Schett G, Smolen J, Zimmermann C et al (2002) The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity. Lupus 11:704\u2013715","journal-title":"Lupus"},{"key":"1130_CR28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.patbio.2005.07.011","volume":"54","author":"I Ghedira","year":"2006","unstructured":"Ghedira I, Landolsi H, Mankai A, Fabien N, Jeddi M (2006) Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: ELISA, dot blot and immunoblot. Pathol Biol (Paris) 54:148\u2013154","journal-title":"Pathol Biol (Paris)"},{"key":"1130_CR29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/1529-0131(200001)43:1<76::AID-ANR10>3.0.CO;2-I","volume":"43","author":"Z Amoura","year":"2000","unstructured":"Amoura Z, Koutouzov S, Chabre H et al (2000) Presence of anti-nucleosome autoantibodies in a restricted set of connective tissue diseases. Arthritis Rheum 43:76\u201384","journal-title":"Arthritis Rheum"},{"key":"1130_CR30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.1780370313","volume":"37","author":"S Sato","year":"1994","unstructured":"Sato S, Ihr H, Kikuchi K, Takehara K (1994) Antih-histone antibodies in systemic sclerosis: association with pulmonary fibrosis. Arthritis Rheum 37:391\u2013394","journal-title":"Arthritis Rheum"},{"key":"1130_CR31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.57.8.470","volume":"57","author":"M Hasegawa","year":"1998","unstructured":"Hasegawa M, Sato S, Kikuchi K, Takehara K (1998) Antigen specificity of anti-histone antibodies in systemic sclerosis. Ann Rheum Dis 57:470\u2013475","journal-title":"Ann Rheum Dis"},{"issue":"supp1","key":"1130_CR32","first-page":"S73","volume":"10","author":"JA Gomez-Puerta","year":"2001","unstructured":"Gomez-Puerta JA, Molina JF, Anaya JM, Molina J (2001) Clinical significance anti-chromatin antibodies in systemic lupus erythematosus. Lupus 10(supp1):S73","journal-title":"Lupus"},{"key":"1130_CR33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1529-0131(200201)46:1<280::AID-ART10079>3.0.CO;2-A","volume":"46","author":"Y Hmida","year":"2002","unstructured":"Hmida Y, Schmit P, Gilson G, Humbel RL (2002) Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al. Arthritis Rheum 46:280\u2013282","journal-title":"Arthritis Rheum"},{"key":"1130_CR34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaut.2003.12.005","volume":"22","author":"A Ghirardello","year":"2004","unstructured":"Ghirardello A, Doria A, Zampieri S et al (2004) Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimm 22:235\u2013240","journal-title":"J Autoimm"},{"key":"1130_CR35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1191\/0961203306lu2325oa","volume":"15","author":"JA Gomez-Puerta","year":"2006","unstructured":"Gomez-Puerta JA, Burlingame RW, Cervera R (2006) Anti-chromatin (anti-nucleosome) antibodies. Lupus 15:408\u2013411","journal-title":"Lupus"},{"key":"1130_CR36","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/art.1780371213","volume":"37","author":"DJ Wallace","year":"1994","unstructured":"Wallace DJ, Lin HC, Shen GQ (1994) Antibodies to histone (H2A\u2013H2B) DNA complexes in the absence of antibodies to double-strand DNA or to (H2A\u2013H2B) complexes are more sensitive and specific for scleroderma\u2013related disorders than for lupus. Arthritis Rheum 37:1795\u20131797","journal-title":"Arthritis Rheum"},{"key":"1130_CR37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1515\/CCLM.2004.049","volume":"42","author":"C Gonzalez","year":"2004","unstructured":"Gonzalez C, Garcia-Berrocal B, Herraez O, Navajo AJ, Gonzalez-Buitrago J (2004) Antinucleosome, antichromatin, anti-ds DNA and anti-histone antibody reactivity in systemic lupus erythematsus. Clin Chem Lab Med 42:266\u2013272","journal-title":"Clin Chem Lab Med"},{"key":"1130_CR38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/CMR.4.3.256","volume":"4","author":"M Fritzler","year":"1991","unstructured":"Fritzler M, Salazar M (1991) Diversity and origin of rheumatology autoantibodies. Clin Microbial Rev 4:256\u2013269","journal-title":"Clin Microbial Rev"},{"key":"1130_CR39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/ard.49.7.524","volume":"49","author":"NR Gompertz","year":"1990","unstructured":"Gompertz NR, Isenberg DA, Turner BM (1990) Correlation between clinical features of systemic lupus erythematosus and levels of antihistone antibodies of the IgG, IgA and IgM isotypes. Ann Rheum Dis 49:524\u2013527","journal-title":"Ann Rheum Dis"},{"key":"1130_CR40","first-page":"13","volume":"20","author":"DJ Min","year":"2002","unstructured":"Min DJ, Kim SJ, Park SH et al (2002) Anti-nucleosome antibody: significance in lupus patients lacking anti-double stranded DNA antibody. Clin Exp Rheum 20:13\u201318","journal-title":"Clin Exp Rheum"},{"key":"1130_CR41","first-page":"230","volume":"18","author":"CE Siegert","year":"1991","unstructured":"Siegert CE, Daha M, Westedt ML (1991) IgG autoantibodies against CIq are correlated with nephritis, hypocomplementaemia, and ds DNA antibodies in systemic lupus disease. J Rheumatol 18:230\u2013234","journal-title":"J Rheumatol"},{"key":"1130_CR42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/ard.52.12.851","volume":"52","author":"CE Siegert","year":"1993","unstructured":"Siegert CE, Daha MR, Tseng CM (1993) Predictive value of IgG autoantibodies against CIq for nephritis in systemic lupus erythematosus. Ann Rheum Dis 52:851\u2013856","journal-title":"Ann Rheum Dis"},{"key":"1130_CR43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1191\/0961203303lu340oa","volume":"12","author":"J Cort\u00e9s-Hern\u00e1ndez","year":"2004","unstructured":"Cort\u00e9s-Hern\u00e1ndez J, Ordi-Ros J, Labrador M (2004) Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methyl prednisolone. Lupus 12:287\u2013298","journal-title":"Lupus"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1130-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1130-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1130-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:34Z","timestamp":1559119894000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1130-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,14]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1130-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,14]]}}}